This study provides insight into the regulation of CTLA-4 in ILCs, and how blockade or genetic deletion of this crucial regulatory molecule leads to exacerbated disease in mouse models of colitis and in patients with conventional IBD and CPI-C. The gene discussed is CTLA4; the disease is inflammatory bowel disease.